{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Niraparib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Niraparib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Niraparib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "niraparib",
    "trial_2_text": "Niraparib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Niraparib Supplement: 60 participants will take Niraparib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Niraparib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Niraparib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.33866268396377563,
      "78": 0.3051998019218445,
      "68": 0.22707538306713104,
      "17": 0.22600418329238892,
      "77": 0.21048562228679657,
      "123": 0.21044915914535522,
      "49": 0.20975543558597565,
      "20": 0.2093438059091568,
      "189": 0.20221996307373047,
      "177": 0.1915721297264099,
      "188": 0.18085306882858276,
      "9": 0.1776605099439621,
      "173": 0.17252732813358307,
      "37": 0.16996583342552185,
      "101": 0.15290051698684692,
      "228": 0.1513572335243225,
      "67": 0.14904329180717468,
      "46": 0.14681152999401093,
      "21": 0.1437615305185318,
      "79": 0.14350910484790802,
      "200": 0.12573453783988953,
      "2": 0.12488812953233719,
      "350": 0.12465100735425949,
      "114": 0.11381988972425461,
      "14": 0.11084971576929092,
      "239": 0.11024447530508041,
      "29": 0.10639988631010056,
      "193": 0.10350041836500168,
      "72": 0.09875243157148361,
      "38": 0.09755825251340866,
      "104": 0.0960189700126648,
      "243": 0.09385121613740921,
      "126": 0.09269944578409195,
      "64": 0.0918409451842308,
      "179": 0.09155324846506119,
      "180": 0.09153416752815247,
      "194": 0.08732607960700989,
      "261": 0.08719382435083389,
      "122": 0.07904870063066483,
      "102": 0.07867273688316345,
      "396": 0.07841325551271439,
      "151": 0.07680947333574295,
      "86": 0.07679072767496109,
      "5": 0.07597194612026215,
      "85": 0.07507235556840897,
      "27": 0.07013430446386337,
      "131": 0.06931605935096741,
      "100": 0.06889140605926514,
      "30": 0.06829213351011276,
      "116": 0.06820929050445557,
      "35": 0.06781191378831863,
      "76": 0.06778901070356369,
      "139": 0.06651411205530167,
      "249": 0.06490656733512878,
      "1": 0.06366430968046188,
      "204": 0.06347360461950302,
      "82": 0.06135528162121773,
      "144": 0.060480330139398575,
      "147": 0.05908399820327759,
      "61": 0.05763334408402443,
      "69": 0.05610376596450806,
      "18": 0.05580383166670799,
      "355": 0.054814621806144714,
      "164": 0.054612595587968826,
      "191": 0.053898610174655914,
      "234": 0.053105805069208145,
      "282": 0.05285867676138878,
      "130": 0.052624836564064026,
      "142": 0.0517338290810585,
      "341": 0.05130324140191078,
      "286": 0.05128290504217148,
      "28": 0.050428979098796844,
      "269": 0.050398584455251694,
      "441": 0.05035216733813286,
      "288": 0.04973839968442917,
      "212": 0.04813249781727791,
      "276": 0.048112642019987106,
      "75": 0.047697022557258606,
      "33": 0.047337308526039124,
      "166": 0.047219447791576385,
      "96": 0.047214705497026443,
      "186": 0.046898022294044495,
      "170": 0.04605711251497269,
      "132": 0.04544152691960335,
      "466": 0.04515736922621727,
      "361": 0.04507029429078102,
      "36": 0.044490281492471695,
      "339": 0.04347878322005272,
      "382": 0.04313112422823906,
      "253": 0.042593225836753845,
      "133": 0.04211283102631569,
      "454": 0.04119977727532387,
      "92": 0.04032037407159805,
      "89": 0.03888004645705223,
      "163": 0.03876197710633278,
      "262": 0.038506098091602325,
      "356": 0.03761660307645798,
      "4": 0.0373784638941288,
      "154": 0.03726779296994209,
      "256": 0.03713621199131012
    },
    "trial_2_ae": {
      "87": 0.33866268396377563,
      "78": 0.3051998019218445,
      "68": 0.22707538306713104,
      "17": 0.22600418329238892,
      "77": 0.21048562228679657,
      "123": 0.21044915914535522,
      "49": 0.20975543558597565,
      "20": 0.2093438059091568,
      "189": 0.20221996307373047,
      "177": 0.1915721297264099,
      "188": 0.18085306882858276,
      "9": 0.1776605099439621,
      "173": 0.17252732813358307,
      "37": 0.16996583342552185,
      "101": 0.15290051698684692,
      "228": 0.1513572335243225,
      "67": 0.14904329180717468,
      "46": 0.14681152999401093,
      "21": 0.1437615305185318,
      "79": 0.14350910484790802,
      "200": 0.12573453783988953,
      "2": 0.12488812953233719,
      "350": 0.12465100735425949,
      "114": 0.11381988972425461,
      "14": 0.11084971576929092,
      "239": 0.11024447530508041,
      "29": 0.10639988631010056,
      "193": 0.10350041836500168,
      "72": 0.09875243157148361,
      "38": 0.09755825251340866,
      "104": 0.0960189700126648,
      "243": 0.09385121613740921,
      "126": 0.09269944578409195,
      "64": 0.0918409451842308,
      "179": 0.09155324846506119,
      "180": 0.09153416752815247,
      "194": 0.08732607960700989,
      "261": 0.08719382435083389,
      "122": 0.07904870063066483,
      "102": 0.07867273688316345,
      "396": 0.07841325551271439,
      "151": 0.07680947333574295,
      "86": 0.07679072767496109,
      "5": 0.07597194612026215,
      "85": 0.07507235556840897,
      "27": 0.07013430446386337,
      "131": 0.06931605935096741,
      "100": 0.06889140605926514,
      "30": 0.06829213351011276,
      "116": 0.06820929050445557,
      "35": 0.06781191378831863,
      "76": 0.06778901070356369,
      "139": 0.06651411205530167,
      "249": 0.06490656733512878,
      "1": 0.06366430968046188,
      "204": 0.06347360461950302,
      "82": 0.06135528162121773,
      "144": 0.060480330139398575,
      "147": 0.05908399820327759,
      "61": 0.05763334408402443,
      "69": 0.05610376596450806,
      "18": 0.05580383166670799,
      "355": 0.054814621806144714,
      "164": 0.054612595587968826,
      "191": 0.053898610174655914,
      "234": 0.053105805069208145,
      "282": 0.05285867676138878,
      "130": 0.052624836564064026,
      "142": 0.0517338290810585,
      "341": 0.05130324140191078,
      "286": 0.05128290504217148,
      "28": 0.050428979098796844,
      "269": 0.050398584455251694,
      "441": 0.05035216733813286,
      "288": 0.04973839968442917,
      "212": 0.04813249781727791,
      "276": 0.048112642019987106,
      "75": 0.047697022557258606,
      "33": 0.047337308526039124,
      "166": 0.047219447791576385,
      "96": 0.047214705497026443,
      "186": 0.046898022294044495,
      "170": 0.04605711251497269,
      "132": 0.04544152691960335,
      "466": 0.04515736922621727,
      "361": 0.04507029429078102,
      "36": 0.044490281492471695,
      "339": 0.04347878322005272,
      "382": 0.04313112422823906,
      "253": 0.042593225836753845,
      "133": 0.04211283102631569,
      "454": 0.04119977727532387,
      "92": 0.04032037407159805,
      "89": 0.03888004645705223,
      "163": 0.03876197710633278,
      "262": 0.038506098091602325,
      "356": 0.03761660307645798,
      "4": 0.0373784638941288,
      "154": 0.03726779296994209,
      "256": 0.03713621199131012
    }
  },
  "safety": {
    "trial_1_safety": 0.3984503149986267,
    "trial_2_safety": 0.3984503149986267
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4803178906440735
  }
}